Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids.
海洋性コラーゲン加水分解物は、ウマ関節軟骨細胞オルガノイドにおける変形性関節症の異化・炎症マーカー合成を下方制御し、コラーゲン産生と代謝活性を促進する (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- その他の原著論文
- 対象
- ヒト・動物 併記
- 出版年
- 2021
- 出典
- doi.org
- 抄録の表示
- 表示あり
- 出版状態
- 有効な記録
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/04
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
日本語要約(機械生成)
関節軟骨は修復能が低く、軟骨欠損は変形性関節症(OA)へ進行する。本研究では、魚由来コラーゲン加水分解物(Promerim®30、40、60)のウマ関節軟骨細胞(eAC)オルガノイドへの影響を検討した。その結果、細胞毒性はなく、生理的酸素濃度下で代謝活性を促進し、Promerim®30は細胞老化を遅延させた。低酸素下でBMP-2やIL-1β存在下に培養したオルガノイドでは、Promerim®30と40がI型・II型コラーゲン産生を増加させ、OA関連プロテアーゼ(Htra1、MMP1-3、Adamts5、Cox2)の遺伝子発現を低下させた。また、炎症条件下でHtra1タンパク質量を減少させ、スクラッチアッセイでは細胞増殖・遊走を促進した。これらの結果から、Promerim®30と40はOA症状の緩和と進行遅延に有望なサプリメントであることが示唆された。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
Articular cartilage experiences mechanical constraints leading to chondral defects that inevitably evolve into osteoarthritis (OA), because cartilage has poor intrinsic repair capacity. Although OA is an incurable degenerative disease, several dietary supplements may help improve OA outcomes. In this study, we investigated the effects of Dielen® hydrolyzed fish collagens from skin (Promerim®30 and Promerim®60) and cartilage (Promerim®40) to analyze the phenotype and metabolism of equine articular chondrocytes (eACs) cultured as organoids. Here, our findings demonstrated the absence of cytotoxicity and the beneficial effect of Promerim® hydrolysates on eAC metabolic activity under physioxia; further, Promerim®30 also delayed eAC senescence. To assess the effect of Promerim® in a cartilage-like tissue, eACs were cultured as organoids under hypoxia with or without BMP-2 and/or IL-1β. In some instances, alone or in the presence of IL-1β, Promerim®30 and Promerim®40 increased protein synthesis of collagen types I and II, while decreasing transcript levels of proteases involved in OA pathogenesis, namely Htra1, and the metalloproteinases Mmp1-3, Adamts5, and Cox2. Both Promerim® hydrolysates also decreased Htra1 protein amounts, particularly in inflammatory conditions. The effect of Promerim® was enhanced under inflammatory conditions, possibly due to a decrease in the synthesis of inflammation-associated molecules. Finally, Promerim® favored in vitro repair in a scratch wound assay through an increase in cell proliferation or migration. Altogether, these data show that Promerim®30 and 40 hold promise as dietary supplements to relieve OA symptoms in patients and to delay OA progression.
MeSH
DOI 10.3390/ijms22020580
PMID 33430111
原文・出典を見る →